| Author | Title | Citation | Summary | Year |
| Jack Malich |
A (LOPER) BRIGHT FUTURE?: HOW THE SUPREME COURT OPENED A PATH FOR DRUG REFORM |
65 Santa Clara Law Review 405 (2024-2025) |
We are witnessing a sweeping transformation of administrative law. The Supreme Court has taken aim at what it believes is a constitutional error: the power of the administrative state. All parts of the so-called fourth branch of government are undergoing shifts in the legal doctrines governing their structure. For those in favor of a strong... |
2025 |
| Christian Z. MacDonald |
A BLUNT REALITY: HOW § 922(G)(3) OF THE GUN CONTROL ACT VIOLATES THE SECOND AMENDMENT RIGHTS OF MARIJUANA USERS |
78 SMU Law Review Forum 115 (November, 2025) |
Over 98% of Americans live in a state that has some form of legal marijuana, with over half of Americans having used the drug at least once. The United States also has a strong historical tradition of individual gun ownership for the purpose of self-defense; today, gun ownership sits at its highest level in decades. With gun ownership and marijuana... |
2025 |
| Katie Cohen |
A CATALYST FOR REFORM: CHARTING A FUTURE FOR ORPHAN DRUG EXCLUSIVITY |
173 University of Pennsylvania Law Review 907 (February, 2025) |
Introduction. 908 I. Catalyst's Impact on Orphan Drug Exclusivity. 911 A. Orphan Drug Exclusivity and the Orphan Drug Act. 911 B. Implications for Drug Pricing and Patient Access. 913 C. Widening the Scope of Orphan Drug Exclusivity. 914 D. FDA's Response. 918 II. Doctrinal Uncertainty in the Wake of Catalyst. 919 A. Uncertainty for Drug Sponsors.... |
2025 |
| Doron Narotzki , Tamir Shanan |
A COMPREHENSIVE, AND A JOINT, MARIJUANA TAX |
44 Virginia Tax Review 303 (Winter, 2025) |
The long-standing debate over marijuana legalization has reached a critical juncture, signaling a shift in public perception after years of deliberation. A significant number of states have now chosen to legalize marijuana, either for medicinal purposes, recreational use, or both, indicating a growing consensus on the issue. However, this article... |
2025 |
| Emily Nelson |
ACCESS DENIED: WHY INVESTIGATIONAL DRUG ACCESS SHOULD REACH BEYOND LIFE-THREATENING DISEASES |
21 Journal of Health & Biomedical Law 130 (2025) |
A patient with a rare form of cancer sought access to an investigational drug in hopes of a potential cure. Initially, the Food and Drug Administration (hereinafter FDA) denied the patient's request. Although the agency later granted access to the patient, the approval was too late, and the patient passed away two months later. Unlike patients with... |
2025 |
| Piotr Lisowski, L.D. |
ADVANTAGES AND DISADVANTAGES OF SOFT DRUGS LEGALISATION AT STATE LEVEL |
40 Issues in Law and Medicine 17 (Spring, 2025) |
ABSTRACT: The relevance of the study lies in the contrasting perspectives on the legalisation and decriminalisation of soft drugs beyond their medical applications. Although there is ongoing public discussion over the benefits of legalizing soft drugs, Ukraine's current legal system does not represent a cohesive strategy. The study aims to conduct... |
2025 |
| Brendan Bargmann, Robert A. Bohrer |
ALPHAFOLD 3, AI, ANTIBODY PATENTS, THE FUTURE OF BROAD PHARMACEUTICAL PATENT CLAIMS, AND DRUG DEVELOPMENT |
53 AIPLA Quarterly Journal 247 (Spring, 2025) |
I. Introduction. 248 II. The Science of Antibodies. 249 III. Patents. 254 A. The Importance of Patents. 255 B. Patent Claims. 256 C. Antibody Patents: The Evolving Interpretation of Enablement and Undue Experimentation.. 258 IV. The Power of AI to Determine the Structure of Proteins: A Revolution in Biology & the Development of Monoclonal Antibody... |
2025 |
| Abby O'Hern |
ARE AI-ASSISTED DRUG TECHNOLOGIES ADDRESSING OR AGGRAVATING THE OPIOID CRISIS IN THE UNITED STATES? |
128 West Virginia Law Review 265 (Fall, 2025) |
The opioid crisis is a significant public health emergency, intensified by the rise of synthetic opioids such as fentanyl. Lawmakers have described fentanyl as terroristic in nature due to its often-fatal properties. According to the Center for Disease Control (CDC), an estimated 107,543 people died from drug overdoses in the United States in... |
2025 |
| Angela E. Addae |
BOOZE, BARS, AND BIAS: ANTI-BLACKNESS IN LIQUOR LICENSING ENFORCEMENT |
81 Washington and Lee Law Review 1855 (2025) |
This Article explores the disharmonious and disturbing influence of race in the enforcement of liquor licenses. Across the length and breadth of this nation, attentive Black revelers bear witness to an all-too-familiar trend signified by the disproportionately frequent closures of Black entertainment businesses. This Article argues that the... |
2025 |
| Victor C. Romero |
BORDER DECRIMINALIZATION AS A STATE PROJECT: LESSONS FROM MARIJUANA AND ASSISTED SUICIDE LEGALIZATION ACROSS THE UNITED STATES |
32 William and Mary Journal of Race, Gender, and Social 1 Justice(Fall, 2025) |
My prior work argued for the decriminalization of border crossings without proof of specific intent to violate another law (like drug trafficking), which is even less likely to happen now than it was when the piece was published, given the current presidential administration's zealous deportation strategy and Congress's seeming acquiescence. As... |
2025 |
| Eva Lane |
CANNABIS AT WORK: NAVIGATING THE INTERSECTION OF EMPLOYMENT LAW AND LEGALIZED MARIJUANA |
31 Washington and Lee Journal of Civil Rights and Social 269 Justice(Spring, 2025) |
As states increasingly legalize forms of cannabis use, federal regulation remains stagnant. These outdated laws still hold power, undermining state-granted rights. This impact is especially felt in the employment sector. While states pass laws legalizing cannabis use, employers still have a right to a drug free workplace. Many employment agreements... |
2025 |
| Sophia DeChurch |
CANNABIS IN THE CLINK: AN ARGUMENT IN FAVOR OF MEDICAL MARIJUANA FOR DISABLED INMATES |
38 Journal of Law and Health 304 (1-Mar-25) |
Abstract: In recent decades, medical marijuana programs have become commonplace, and most states in the United States of America are ready to accept marijuana as a natural alternative to treat symptoms of certain conditions such as chronic pain, cancer, mental illness, multiple sclerosis (MS), HIV/AIDS, and substance use disorder; as such, medical... |
2025 |
| Melvin L. Otey |
CHRISTIAN FAITH AND MARIJUANA USE AFTER FEDERAL RESCHEDULING |
22 Indiana Health Law Review 351 (2025) |
The general public probably does not realize that marijuana possession remains a federal crime, even in states that have substantially decriminalized its manufacture, distribution, and use. For law-abiding persons, marijuana's status as a Schedule I controlled substance means it cannot be consumed medicinally or recreationally. However, there are... |
2025 |
| R. Mathews Ivey |
CIVIL RICO CLAIMS--THE SUPREME COURT'S EXPANSION OF 18 U.S.C. § 1964(C) TO INCLUDE BUSINESS OR PROPERTY LOSSES THAT ARISE FROM PERSONAL INJURIES--MEDICAL MARIJUANA, INC. v. HORN, 604 U.S. 593 (2025) |
49 American Journal of Trial Advocacy 243 (Fall, 2025) |
The Racketeer Influenced and Corrupt Organizations Act (RICO) was originally enacted in 1970 as a way to address organized crime issues, specifically those issues dealing with the mafia and the mob. Indeed, RICO prosecutions infamously brought down John Gotti and members of New York's Five Families. However, RICO's reach is not limited to... |
2025 |
| H. Justin Pace , Eden Punch |
CONVERGENCE AND DIVERGENCE OF ALCOHOL AND MARIJUANA REGULATION IN A FEDERALIST SYSTEM POST-COVID-19 |
73 University of Kansas Law Review 615 (February, 2025) |
After the passage of the Twenty-first Amendment, the regulation of alcohol in the United States largely takes place at the state level. While marijuana has been illegal at the federal level since 1937, states have been liberalizing marijuana laws at the state level since 1996 by legalizing marijuana for medical or adult use. Alcohol regulation,... |
2025 |
| Andrew Engelson |
CRACKS IN THE SYSTEM |
111-SEP ABA Journal 50 (August/September, 2025) |
It took Norm Brown a while to realize he would likely die in prison. Sentenced to life at the age of 24 for felonies involving crack cocaine, he'd always held out hope he'd someday go free, but he saw each of his options evaporate one by one. I was like a drowning man reaching for a spiderweb, Brown says of the various appeals and attempts at... |
2025 |
| Jonathan Dombro |
DEFYING REASON: HOW DRUG WAR HYSTERIA CREATED AN ENDURING REGIME OF UNCONSTITUTIONALLY DRUG TESTING GOVERNMENT EMPLOYEES |
34 Boston University Public Interest Law Journal 191 (Summer, 2025) |
Abstract. 192 Introduction. 193 I. The Evolution of a Government Drug Test Regime and Corresponding Jurisprudence. 195 A. The Advent of Government Employer Drug Screens. 197 B. Skinner, Reviewed. 198 C. Von Raab,reviewed. 199 D. Tensions Remain, the Court Speaks Again. 200 E. Government Employee Drug Screens Today. 202 II. Marginalized and... |
2025 |
| Taleed El-Sabawi, Sarah Katz |
DEINSTITUTIONALIZING FAMILY SEPARATION IN CASES OF PARENTAL DRUG USE |
134 Yale Law Journal Forum 1022 (2024-2025) |
March 28, 2025 abstract. Family separation has long served as a mechanism of social control and punishment in the United States, disproportionately targeting Black, Indigenous, and other marginalized families under the guise of child welfare. Family separation remains the family policing system's primary intervention in families, including families... |
2025 |
| Jordan Reed |
DON'T DO DRUGS KIDS! UNLESS YOU'RE COLOMBIA . |
56 George Washington International Law Review 181 (2025) |
Colombia is on the verge of taking an unprecedented step--cocaine decriminalization. Colombia's newly elected leftist administration has dared to take this step as an alternative approach to addressing drug-related harms that have plagued the country for decades. Colombian President Gustavo Petro, who is spearheading this new approach to drug... |
2025 |
| Sahil Agrawal, Melissa Barber, Amy Kapczynski, Trudel Pare |
DRUG DEALING: MAKING PUBLIC PHARMA WORK |
103 Washington University Law Review 49 (2025) |
The U.S. market for prescription drugs is failing many Americans. Drug prices in the United States are nearly three times higher than in comparable countries, and evidence shows that patients regularly forego essential medicines because they cannot afford them. Additionally, shortages of important medicines are common. In partial response,... |
2025 |
| Cameron S. Quackenbush |
E-CIGARETTES AS WASTE AND THE NEED TO REGULATE "DISPOSABLE" PRODUCTS |
55 Environmental Law Reporter (ELI) 10219 (March/April, 2025) |
Between January 2020 and March 2023, U.S. electronic cigarette sales grew 43%, from 15.6 million devices per month to 22.4 million devices. During this time frame, the portion of sales comprising disposable devices grew from 4 million to 11.9 million per month. The impact upon the environment has been largely overlooked by policymakers. Containing... |
2025 |
| Brian Wright |
EQUITABLY SHIFTING THE BURDEN: EUROPEAN DAY FINES AS AN ALTERNATIVE TO IMPRISONMENT FOR DRUG OFFENSES |
26 Oregon Review of International Law 285 (2025) |
Abstract. 286 Introduction. 286 I. Defining the Problem. 287 A. Mass Incarceration in America: Drug Offenses. 287 B. Income Inequality and Unequal Impact of the Current Pecuniary Punishment Scheme. 290 II. The Solution. 292 A. Finland. 293 B. Sweden. 295 C. Germany. 296 D. U.S. Experimentation. 298 III. Applying the Solution. 299 A. Analyzing and... |
2025 |
| Paul Helms |
FIGHTING DRUGS WITH DRUGS: MEDICAL MUSHROOMS IN UTAH'S WAR ON OPIOIDS |
2025 Utah Law Review 529 (2025) |
According to the Utah Department of Health, in 2022 168 individuals died from prescription opioid overdose in Utah, down from the average of 323 people per year between 2016 and 2018. In 2021, the Utah Attorney General announced Utah's portion of a $26 billion settlement from major pharmaceutical companies over the mismanagement of opioids that... |
2025 |
| Lars Noah |
FLAWS IN THE PREEMPTION DEFENSE TO LIABILITY CLAIMS AGAINST GENERIC DRUG MANUFACTURERS |
79 University of Miami Law Review 431 (Spring, 2025) |
More than a dozen years have passed since the U.S. Supreme Court decided that federal preemption protects manufacturers of generic (but not brand-name) drugs from most types of products liability claims. This seemingly arbitrary distinction sprang from a peculiarity in the regulations of the U.S. Food and Drug Administration (FDA). That agency soon... |
2025 |
| Ifetayo Harvey |
FRAGILE GAINS, PERSISTENT SETBACKS: THE MUDDLED ARC OF AMERICAN DRUG-LAW REFORM |
134 Yale Law Journal Forum 932 (2024-2025) |
March 28, 2025 This Collection, which analyzes the legal, social, and political dimensions of drug decriminalization in the context of current debates, comes at a pivotal moment for advocates of drug-policy reform. Two narratives of drug-policy reform have emerged in recent decades. One is a story of swift but fragile gains. Since 2012, twenty-four... |
2025 |
| David A. Simon |
GATEKEEPING DRUGS |
57 Arizona State Law Journal 289 (Spring, 2025) |
How much evidence should pharmaceutical manufacturers be required to provide before they can market new drugs? With drug costs ballooning to over $500 million and marketing approval decisions increasingly contested, scholars have reached two conflicting views. Public-health scholars tend to think high evidentiary standards overseen by a strong... |
2025 |
| Hannah Haight |
HIGH CRIMES IN LOW AIRSPACE: THE RISE OF DRONES IN CROSS-BORDER DRUG TRAFFICKING |
90 Journal of Air Law and Commerce 327 (Summer, 2025) |
Can the United States effectively regulate its airspace when criminal actors exploit it without entering traditional territorial channels? Mexican drug trafficking organizations increasingly deploy drones to deliver narcotics across the U.S.-Mexico border. These flights often occur at low altitudes, at night, and in remote areas, which renders them... |
2025 |
| Callie Terris , Emma Tumilty |
HIGH HOPES: LEGAL AND ETHICAL ISSUES WITH POST-TRIAL ACCESS TO PSYCHEDELIC DRUGS |
28 Journal of Health Care Law and Policy 1 (2025) |
The United States is facing a mental health crisis. Yet, treatment options for complex conditions like Post-Traumatic Stress Disorder (PTSD) remain inadequate, inaccessible, or unaffordable for many. The urgent need for innovative therapies revived clinical investigations into the use of psychedelic drugs to treat mental health conditions. This... |
2025 |
| Frances Alaina Rodriguez |
IF YOU CAN'T BEAT HEMP, JOIN HEMP: A POLICY ARGUMENT FOR A FEDERAL REGULATORY FRAMEWORK ENCOMPASSING INTOXICATING HEMP DERIVATIVES AND MARIJUANA AND WHY RE-SCHEDULING MARIJUANA ISN'T THE ANSWER |
33 University of Miami Business Law Review 469 (Spring, 2025) |
The Agriculture Improvement Act of 2018 (2018 Farm Bill) legalized industrial hemp and its downstream uses by removing hemp from the definition of marijuana under the Controlled Substances Act (CSA). Its enactment led to the explosion of a multi-billion dollar intoxicating hemp derivatives (IHD) market. This boom, combined with growing state-level... |
2025 |
| Meyke A. Kang, Ph.D. |
INCENTIVIZING LOWER DRUG PRICES THROUGH PATENT EXTENSION |
103 North Carolina Law Review 1245 (May, 2025) |
Awarding inventors with a legal monopoly through patents and regulatory exclusivities has proven to be a highly effective tool for making therapeutics more available to society, driving pharmaceutical companies to invest billions of dollars in high-risk, time-consuming research and development. However, this increased availability has come at a... |
2025 |
| Clare Van Prooyen |
INDIANA DRUG COURTS: ELIMINATING TEMPORARY-EVENT RELAPSE SANCTIONS |
58 Indiana Law Review 661 (2025) |
Michael Pawlowski was a working professional in New York City who struggled with substance abuse. In 2010, Michael was convicted of a drunk driving offense and placed in a New York Drug Treatment Court in lieu of incarceration. Michael recognized his struggle with substance abuse, sought help, and was proudly stable in recovery. On July 4, 2012, at... |
2025 |
| Sarah Brown |
INDIANA'S PUNITIVE RESPONSES TO PRENATAL MARIJUANA USE: A RECOMMENDATION FOR THE INDIANA LEGISLATURE |
22 Indiana Health Law Review 125 (2025) |
Forty-three years ago, President Ronald Reagan stated marijuana was probably the most dangerous drug in the United States. Reagan's presidency was, in part, defined by his expansion of President Richard Nixon's proclaimed War on Drugs, an era of United States' law and policy which increased punishment for use and possession of many illegal... |
2025 |
| Randall Petronko |
IT IS TIME TO ADMIT DEFEAT IN THE WAR ON DRUGS AND ALLOW ITS VICTIMS TO HEAL |
22 Rutgers Journal of Law & Public Policy 161 (Spring, 2025) |
C1-2Table of Contents Part 1: Background. 163 How It's Going. 163 History of Prohibition and Criminalization. 167 Part 2: Controlled Substances. 179 LSD. 179 MDMA. 183 Psilocybin. 188 Part 3: Modern Research and Uses. 190 Neurogenesis and Neuroplasticity. 190 Current Studies. 194 Part 4: Policy Suggestions. 199 Harm Reduction. 200 Addressing the... |
2025 |
| Joanna Wang , Insilico Medicine, 1000 Massachusetts Avenue, Suite 126, Cambridge, MA 02138, United States |
NAVIGATING THE USPTO'S AI INVENTORSHIP GUIDANCE IN AI-DRIVEN DRUG DISCOVERY |
12 Journal of Law & the Biosciences 1 (July-December, 2025) |
In February 2024, the United States Patent and Trademark Office (USPTO) issued a notice, Inventorship Guidance for AI-assisted Inventions (Inventorship Guidance), to clarify agency policy and the Office's interpretation of inventorship requirements for patents that describe inventions made with the assistance of artificial intelligence (AI). From... |
2025 |
| Marc A. Rodwin , School of Law, Suffolk University, Boston, United States |
NEGOTIATING MEDICARE DRUG PRICES: A NEW ATTEMPT TO CONTROL PURCHASE PRICES |
53 Journal of Law, Medicine & Ethics 147 (Spring, 2025) |
The Inflation Reduction Act (IRA) creates a new process to cap Medicare Part D branded drug prices. It prohibits Medicare from paying more than a specified discount from average private market prices and requires that CMS negotiate with manufacturers to agree on a maximum fair price that Medicare will pay that is lower than the specified discount.... |
2025 |
| Katharina Ó Cathaoir , Margherita Melillo , Roger S. Magnusson |
NON-COMMUNICABLE DISEASE: CHALLENGES AND OPPORTUNITIES FOR GLOBAL REGULATION OF TOBACCO, UNHEALTHY FOOD, AND ALCOHOL |
53 Journal of Law, Medicine & Ethics 30 (Spring, 2025) |
Non-communicable diseases (NCDs) represent a significant global health challenge, requiring distinct prevention and control strategies. Public health efforts have concentrated on regulating three primary risk factors: tobacco and nicotine products, unhealthy foods and beverages, and alcohol. While the World Health Organization (WHO) Framework... |
2025 |
| Orly Lobel |
OLIGOPOLY SQUARED: FEDERALISM AND THE NEW LEGAL LANDSCAPE TACKLING THE DARK WEB OF DRUG PRICING |
111 Virginia Law Review 1673 (December, 2025) |
The pharmaceutical industry's billion-dollar practice of inflating drug prices and shielding itself from accountability has brought immense public outcry and inspired a profusion of legal reforms. But the precise dynamics that enable this ongoing crisis remain obscure, impeding effective resolution. This Article examines the interplay between... |
2025 |
| Roslyn Thelliyankal |
ORPHANED AGAIN: REVISITING THE ORPHAN DRUG ACT AND PRIORITIZING PATIENT ACCESS TO MEDICINE |
17 Drexel Law Review 567 (2025) |
In 1983, Congress passed the Orphan Drug Act (ODA) as part of an effort to provide market incentives for pharmaceutical manufacturers to produce orphan drugs, drugs for diseases that impact less than two hundred thousand people in the United States annually. Prior to the passage of the ODA, rare-disease patients had little to no treatment... |
2025 |
| Mitchell F. Crusto |
PARDON ME PLEASE: EVALUATING CLEMENCY FOR MARIJUANA OFFENDERS |
83 Washington and Lee Law Review Online 1 (2025) |
Since 2012, several states and municipalities have decriminalized the non-violent use and possession of small amounts of recreational marijuana by adults. These criminal law reforms raise the issue of whether individuals who were convicted in the past should be exonerated retroactively by way of pardons or clemency. Consequently, many past... |
2025 |
| Andrew Gilden , Sarah R. Wasserman Rajec |
PATENTING THE TABOO: SEX, DRUGS, AND ABORTION |
27 Yale Journal of Law and Technology 474 (2025) |
The patent system provides a surprisingly rich archive of the interplay between social norms and technological change. Patent law requires applicants to publicly disclose the novelty and usefulness of their inventions, thereby bringing to light areas of innovation that may have previously lived in the shadows. In other words, patent law encourages... |
2025 |
| Heather M. Petruzzi, Jerry A. Salvatore, Patrick E. Nyman |
PATENTS AND DRUG PRICING |
17 Landslide 26 (March/April, 2025) |
The price of branded drugs in the United States has been and continues to be a hot topic. While various causes have been alleged, recent attention has focused heavily on the U.S. patent system. Lawmakers, the U.S. Patent and Trademark Office (USPTO), and even the former president have called for or sought to push through substantial changes to the... |
2025 |
| Thomas Starks |
PITTSBURGH ORDINANCE LIMITS PREEMPLOYMENT MEDICAL MARIJUANA SCREENING -- ADDS TO PATCHWORK LAW FOR EMPLOYERS |
47-APR Pennsylvania Lawyer 18 (March/April, 2025) |
In 2024, Pittsburgh enacted a new ordinance addressing medical marijuana. The ordinance puts medical marijuana users in a protected class for employment purposes, right alongside the protected classes of gender, race and religion. This new ordinance prevents employers from discriminating against medical marijuana use in the employment process,... |
2025 |
| Elenore Wade |
PRIVATE CONTROL IN MEDICARE'S OFF-LABEL DRUG COVERAGE |
57 Arizona State Law Journal 1141 (Fall, 2025) |
Every year, Medicare Part D denies thousands of claims for medically necessary prescription drugs, not by accident or error, but by statute. Part D's statutory compendium restriction limits coverage of drugs used off-label unless those uses are recommended by the editors of two private drug databases that are functionally inaccessible to the... |
2025 |
| Bennett Capers, Jeffrey Bellin |
RACE, THE ACADEMY, AND THE CONSTITUTION OF THE WAR ON DRUGS, THE CONSTITUTION OF THE WAR ON DRUGS BY DAVID POZEN, OXFORD UNIVERSITY PRESS, 2024 |
134 Yale Law Journal 1763 (March, 2025) |
The war on drugs is widely viewed as a policy failure. Despite massive government intrusions on personal liberty, drug addiction, overdoses, and drug-related violence have only increased since the war was declared in 1971. David Pozen's new book, The Constitution of the War on Drugs, reveals a constitutional failure as well. Pozen chronicles a host... |
2025 |
| Hannah Rahim, BHSc |
REDUCING DISCRIMINATION IN ORGAN TRANSPLANT CANDIDACY EVALUATION AGAINST PERSONS WHO USE DRUGS |
34 Annals of Health Law and Life Sciences 189 (Winter, 2025) |
Many organ transplant centers deny persons who use drugs eligibility for receiving a transplant because of concerns about the impact of drugs on transplant success. These policies are often not based on sufficient medical evidence and are highly variable between transplant centers. Restricting persons who use drugs from organ transplantation can... |
2025 |
| Laura G. Abelson |
REEVALUATING FELON-IN-POSSESSION LAWS AFTER BRUEN AND THE WAR ON DRUGS |
15 UC Irvine Law Review 871 (October, 2025) |
The legal landscape surrounding firearm possession is evolving rapidly. In 2022, the Supreme Court accelerated its expansion of the individual right to bear arms under the Second Amendment in New York Rifle & Pistol Ass'n v. Bruen. Since Bruen, courts around the country have struck down nearly all types of firearm regulations, with a notable... |
2025 |
| Caroline Beckworth |
REMEDIATING PUBLIC HEALTH CRISES THROUGH LITIGATION: LESSONS FROM OKLAHOMA IN THE TOBACCO AND OPIOID EPIDEMIC LITIGATIONS |
77 Oklahoma Law Review 747 (Summer, 2025) |
Public health crises caused by corporate misconduct, such as the tobacco and opioid epidemics, have devastated communities across America. Litigation brought by state attorneys general has proven an effective tool for holding wrongdoers accountable and securing monetary recoveries to mitigate these harms. However, ensuring these funds are properly... |
2025 |
| Mason Marks |
SEPARATION OF DRUG SCHEDULING POWERS |
134 Yale Law Journal Forum 976 (2024-2025) |
March 28, 2025 abstract. Drug scheduling places substances believed to be harmful and addictive under strict federal control. In 1970, Congress enacted the Controlled Substances Act (CSA), which split drug scheduling authority between executive departments to leverage their specialized expertise. Today, the CSA grants the Department of Health and... |
2025 |
| Julia M. Williams |
SHOULD WE CONTINUE OVERLOOKING ANIMAL DRUG RESIDUE IN OUR FOOD? |
28 Quinnipiac Health Law Journal 1 (2025) |
Introduction. 3 I. Agricultural Drug Use in Animals Creates Drug Residue in Human Food. 6 a. Drugs Used on Agricultural Animals. 7 b. Drug Residue in Human Food. 11 c. Health Implications of Drug Residue. 13 II. Control, Monitoring, and Warning of Drug Residue. 15 a. Adulterated Food. 16 i. Tolerance Limits and Withdrawal Periods. 16 ii. National... |
2025 |
| Danny Finley |
STATE PRESCRIPTION DRUG AFFORDABILITY BOARDS: THE KEY TO EXPANDED ACCESS TO MEDICARE-NEGOTIATED DRUG PRICES |
37 Health Lawyer 20 (April, 2025) |
Despite record rates of health insurance, nearly 30% of American adults who take prescriptions report not taking medicine as prescribed due to its high cost. Since the passage of Medicare Part D in 2003, the federal government has taken little action to lower drug costs, let alone lower list prices. States should consider extending... |
2025 |